Despite more than 600 reports of "adverse events" for medicinal cannabis in the past three years, the Therapeutic Goods Administration (TGA) is yet to investigate the safety of most medicinal cannabis products. It has now launched a review.

The whole article is worth reading but this caught my eye.

The Australian Medicinal Cannabis Association (AMCA) said that without suspected adverse events being published and investigated it was hard to draw conclusions about the safety of medicinal cannabis products.

If the only organisation representing cannabis prescribers is unwilling to comment on safety what does that say about the state of the industry?

  • givesomefucks@lemmy.worldEnglish
    0·
    1 month ago

    Do you think 13million individuals have cannabis prescriptions?

    …

    You think every single person only used one dose in three years?

    You literally have no idea what you’re talking about here.

    If you’re nicer, people might help you understand

    • Joshi@slrpnk.netOPEnglish
      0·
      1 month ago

      I apologise for not being clearer. My point was that your calculation is wrong. You would need to calculate per patient which is not a published figure. Estimates are more like 1mil but I think that is based on faulty reasoning as my subjective experience is that most people remain on it for only a few months. Also that the vast majority of adverse events go unreported